World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: JPRN
Last refreshed on: 17 October 2023
Main ID:  JPRN-UMIN000005382
Date of registration: 05/04/2011
Prospective Registration: No
Primary sponsor: Higashi Ohmiya general hospital
Public title: Intraoperative perineural infiltration of ropivacaine for acute postlaminectomy pain
Scientific title: Intraoperative perineural infiltration of ropivacaine for acute postlaminectomy pain - Intraoperative perineural infiltration of ropivacaine for acute postlaminectomy pain
Date of first enrolment: 2010/12/01
Target sample size: 60
Recruitment status: Complete: follow-up complete
URL:  https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000006391
Study type:  Interventional
Study design:  Parallel Randomized  
Phase:  Not selected
Countries of recruitment
Japan
Contacts
Name:     Yumiko kohno
Address:  5-18,Higashiomiya,minuma-ku,Saitama city,Japan Japan
Telephone: 0486847111
Email: ykohno-ymi@umin.ac.jp
Affiliation:  Higashi Ohmiya general hospital anesthesiology
Name:     Yumiko kohno
Address:  5-18,Higashiomiya,minuma-ku,Saitama city,Japan Japan
Telephone: 0486847111
Email: ykohno-ymi@umin.ac.jp
Affiliation:  Higashi Ohmiya general hospital anesthesiology
Key inclusion & exclusion criteria
Inclusion criteria:
Exclusion criteria: AST ,ALT>30 Cr>2 reoperation

Age minimum: 20years-old
Age maximum: 75years-old
Gender: Male and Female
Health Condition(s) or Problem(s) studied
lumbar spinal stenosis
Intervention(s)
General anesthesia and NSAIDs. As a contorol,saline 10ml infiltrate per one interspinal segment.
Generalanesthesia and NSAIDs. 0.2%ropivacaine 10ml infiltrate per one interspinal segment.
General anesthesia and NSAIDs. From catheter in injury part,administration of 0.2%ropivacaine 6ml/h. Duration of administration:2 days after the operation.
Primary Outcome(s)
VAS
Secondary Outcome(s)
Secondary ID(s)
Source(s) of Monetary Support
Higashi Ohmiya general hospital
Secondary Sponsor(s)
Ethics review
Status: YES
Approval date:
Contact:
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history